Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 995 of 1,261
  1. US 7759361

    Azabicyclooctan-3-one derivatives and use thereof

    APREA AB · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  2. US 7759348

    Pyridazine derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  3. US 7759339

    Hydroxysteroid dehydrogenase inhibitors

    Takeda San Diego, Inc. · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  4. US 7759338

    Soluble 1,4 benzodiazepine compounds and stable salts thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  5. US 7759313

    Induction method for cell differentiation

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  6. US 7759330

    21-substituted progesterone derivatives as new antiprogestational agents

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  7. US 7759106

    Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (CfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic E. coli

    The United States of America as represented by the Secretary of the Army · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  8. US 7759320

    Compositions and methods for inhibiting expression of a gene from the Ebola

    Alnylam Pharmaceuticals, Inc. · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  9. US 7758898

    Copper lowering treatment of inflammatory and fibrotic diseases

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  10. US 7758858

    Antibodies associated with alterations in bone density

    Darwin Discovery Limited · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  11. US 7759335

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Jenrm Discovery, Inc. · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  12. US 7759304

    Targeting complement factor H for treatment of diseases

    The Regents of the University of Colorado · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  13. US 7759081

    Annexin proteins and autoantibodies as serum markers for cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  14. US 7758855

    DNA promoters and anthrax vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  15. US 7759500

    2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted
  16. US 7754872

    Liposomal phosphodiester, phophorothioate, and p-ethoxy oligonucleotides

    The Board of Regents of the University of Texas System · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted
  17. US 7754856

    Human sodium-dependent bile acid transporter proteins

    Takeda Pharmaceutical Company Limited · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted
  18. US 7754739

    Modulators of CFTR

    Vertex Pharmaceuticals Incorporated · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted
  19. US 7754220

    Methods of inhibiting secretion of follicle-stimulating hormone and testosterone

    Takeda Pharmaceutical Company Limited · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted
  20. US 7754461

    Large-scale production of human serum butyrylcholinesterase as a bioscavenger

    The United States of America as represented by the Secretary of the Army · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted
  21. US 7754420

    Methods of using cyanovirins to inhibit viral infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted
  22. US 7754676

    Defensin-antigen fusion proteins

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted
  23. US 7754230

    Methods and related compositions for reduction of fat

    The Regents of the University of California · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted
  24. US 7754711

    Pyridazine derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.